The compound huperzine A can increase resistance to induced seizures in mouse models of genetic epilepsy, scientists have found. In particular, huperzine A shows potential for protecting against ...

Existing evidence suggests that patients with Alzheimer's disease who have taken Huperzine A have improved general cognitive function, global clinical status, functional performance and reduced ...

Our preliminary results show that huperzine A, an acetylcholinesterase inhibitor used to treat Alzheimer's disease (AD) patients in China, exhibits different pharmacokinetic features in elderly and ...

Huperzine-A is an alkaloid compound derived from the herb Huperzia serrata and is an ingredient of herbal formulas used in Chinese medicine to treat Alzheimer's disease and age-related cognitive ...

(–)-Huperzine A 1, originally called (–)-selagine A, is a natural compound that was first reported in the literature in 1937 in an article by Polish researcher Piotr Oficjalski about the toxicity of ...

To investigate the effects of M3, a derivative of huperzine A, on the apoptosis induced by sodium nitroprusside (SNP) in PC12 cells. Cell viability was detected using MTT method. Apoptosis was ...

Shasun Pharmaceuticals and Debiopharm Group entered into a licensing agreement for the manufacturing and commercialization of Huperzine-A, which is a reversible acetylcholinesterase inhibitor.

Existing evidence suggests that patients with Alzheimer’s disease who have taken Huperzine A have improved general cognitive function, global clinical status, functional performance and reduced ...